
Diana Isaacs, PharmD, and Natalie Bellini, DNP, review OPTIMAL-DIABETES, SYNCHRONIZE-CVOT, and ATTAIN-OSA data from AHA 2026.
How do low- and high-normal levels of IGF-1 impact cognitive function and wellbeing during growth hormone replacement? Answers from a new study.



